These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24390737)

  • 1. Overexpression of the transcription factor MEF2D in hepatocellular carcinoma sustains malignant character by suppressing G2-M transition genes.
    Ma L; Liu J; Liu L; Duan G; Wang Q; Xu Y; Xia F; Shan J; Shen J; Yang Z; Bie P; Cui Y; Bian XW; Prieto J; Avila MA; Qian C
    Cancer Res; 2014 Mar; 74(5):1452-62. PubMed ID: 24390737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEF2D overexpression contributes to the progression of osteosarcoma.
    Yu H; Sun H; Bai Y; Han J; Liu G; Liu Y; Zhang N
    Gene; 2015 Jun; 563(2):130-5. PubMed ID: 25814384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pokemon promotes the invasiveness of hepatocellular carcinoma by enhancing MEF2D transcription.
    Kong J; Liu X; Li X; Wu J; Wu N; Chen J; Fang F
    Hepatol Int; 2016 May; 10(3):493-500. PubMed ID: 26797719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDA-7/IL-24 suppresses tumor adhesion and invasive potential in hepatocellular carcinoma cell lines.
    Huo W; Li ZM; Zhu XM; Bao YM; An LJ
    Oncol Rep; 2013 Aug; 30(2):986-92. PubMed ID: 23722307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocyte enhancer factor 2D promotes tumorigenicity in malignant glioma cells.
    Zhao Y; Li Y; Ma Y; Wang S; Cheng J; Yang T; Sun Z; Kuang Y; Huang H; Fan K; Gu J
    Tumour Biol; 2016 Jan; 37(1):601-10. PubMed ID: 26234765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma.
    Wang L; Guo ZY; Zhang R; Xin B; Chen R; Zhao J; Wang T; Wen WH; Jia LT; Yao LB; Yang AG
    Carcinogenesis; 2013 Aug; 34(8):1773-81. PubMed ID: 23615404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686.
    Wu BH; Chen H; Cai CM; Fang JZ; Wu CC; Huang LY; Wang L; Han ZG
    Oncotarget; 2016 Feb; 7(6):6847-63. PubMed ID: 26760772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEF2D/Wnt/β-catenin pathway regulates the proliferation of gastric cancer cells and is regulated by microRNA-19.
    Xu K; Zhao YC
    Tumour Biol; 2016 Jul; 37(7):9059-69. PubMed ID: 26762410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns.
    Cai J; Zhao XL; Liu AW; Nian H; Zhang SH
    Phytomedicine; 2011 Mar; 18(5):366-73. PubMed ID: 20850954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pokemon and MEF2D co-operationally promote invasion of hepatocellular carcinoma.
    Hong X; Hong XY; Li T; He CY
    Tumour Biol; 2015 Dec; 36(12):9885-93. PubMed ID: 26164003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference against granulin-epithelin precursor prevents hepatocellular carcinoma growth: its application as a therapeutic agent.
    Park MY; Park YS; Nam JH
    Int J Oncol; 2011 Oct; 39(4):853-61. PubMed ID: 21701774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.
    Lu Y; Yue X; Cui Y; Zhang J; Wang K
    Biochem Biophys Res Commun; 2013 Nov; 441(4):873-9. PubMed ID: 24211205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma.
    Xie Q; Chen X; Lu F; Zhang T; Hao M; Wang Y; Zhao J; McCrae MA; Zhuang H
    Cancer; 2012 May; 118(9):2431-42. PubMed ID: 21989846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of ARNT2 promotes tumor growth and predicts poor prognosis in human hepatocellular carcinoma.
    Li W; Liang Y; Yang B; Sun H; Wu W
    J Gastroenterol Hepatol; 2015 Jun; 30(6):1085-93. PubMed ID: 25611915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homeobox B9 is overexpressed in hepatocellular carcinomas and promotes tumor cell proliferation both in vitro and in vivo.
    Li F; Dong L; Xing R; Wang L; Luan F; Yao C; Ji X; Bai L
    Biochem Biophys Res Commun; 2014 Feb; 444(2):241-7. PubMed ID: 24462859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
    Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
    Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.
    Zhang SH; Qian YM; Liu AW; Cai J; Zhao XL; Wei JJ; Zhu MH
    Hum Pathol; 2012 Jul; 43(7):1084-93. PubMed ID: 22204716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.